Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Multicentric Asian Registry (IMPACT-Endo-Asia)

NCT07354087 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT07354087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07354087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Multicentric Asian Registry (IMPACT-Endo-Asia)
Lead sponsor
Tata Memorial Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
November 28, 2024
Completion date
November 27, 2026
Enrollment
300 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer